CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions	3 Months Ended		9 Months Ended
	Mar. 28, 2025	Mar. 29, 2024	Mar. 28, 2025	Mar. 29, 2024
Income Statement [Abstract]
Revenue, net	$ 1,695,000,000	$ 1,705,000,000	$ 5,454,000,000	$ 4,903,000,000
Cost of revenue	1,313,000,000	1,242,000,000	3,740,000,000	4,467,000,000
Gross profit	382,000,000	463,000,000	1,714,000,000	436,000,000
Operating expenses:
Research and development	285,000,000	277,000,000	847,000,000	763,000,000
Selling, general and administrative	139,000,000	107,000,000	411,000,000	338,000,000
Goodwill impairment	1,830,000,000	0	1,830,000,000	0
Business separation costs	9,000,000	12,000,000	50,000,000	46,000,000
Employee termination and other	0	2,000,000	5,000,000	(44,000,000)
Gain on business divestiture	0	0	(34,000,000)	0
Total operating expenses	2,263,000,000	398,000,000	3,109,000,000	1,103,000,000
Operating income (loss)	(1,881,000,000)	65,000,000	(1,395,000,000)	(667,000,000)
Interest and other expense:
Interest income	6,000,000	3,000,000	11,000,000	9,000,000
Interest expense	(16,000,000)	(9,000,000)	(22,000,000)	(31,000,000)
Other expense, net	(10,000,000)	(5,000,000)	(55,000,000)	(11,000,000)
Total interest and other expense, net	(20,000,000)	(11,000,000)	(66,000,000)	(33,000,000)
Income (loss) before taxes	(1,901,000,000)	54,000,000	(1,461,000,000)	(700,000,000)
Income tax expense	32,000,000	27,000,000	157,000,000	92,000,000
Net income (loss)	$ (1,933,000,000)	$ 27,000,000	$ (1,618,000,000)	$ (792,000,000)
Net income (loss) per common share:
Basic (in dollars per share)	$ (13.33)	$ 0.19	$ (11.16)	$ (5.46)
Diluted (in dollars per share)	$ (13.33)	$ 0.19	$ (11.16)	$ (5.46)
Weighted average shares outstanding:
Basic (in shares)	145	145	145	145
Diluted (in shares)	145	145	145	145